Establishment Labs to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Establishment Labs to Present at the 43rd Annual J.P. Morgan Healthcare Conference

NEW YORK, January 15, 2025 – Establishment Labs Holdings Inc. (NASDAQ: ESTA), a company devoted to enhancing women’s health and wellness, will present at the 43rd Annual J.P. Morgan Healthcare Conference. CEO Juan José Chacón-Quirós and CFO Raj Denhoy will lead the discussion scheduled for 3:45 PM Pacific Time.

A live webcast will be available on the company’s investor relations site, with an archived version accessible after the event. For more details, visit Establishment Labs Investor Relations.

About Establishment Labs

Establishment Labs Holdings Inc. aims to enhance women’s health through innovative medical technology. With a portfolio focused on breast aesthetics and reconstruction, the company has introduced nearly four million Motiva® devices globally since 2010. The Motiva Flora® tissue expander has set a new standard for safety in breast reconstruction following cancer. With over 200 patents and 100 clinical studies, Establishment Labs remains at the forefront of Femtech solutions. Their manufacturing facilities in Costa Rica comply with all regulatory standards under ISO13485:2016 and FDA mandates.

Contact

For inquiries, please contact Raj Denhoy at 415-828-1044 or via email at rdenhoy@establishmentlabs.com.